Rein Therapeutics (RNTX) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q2 2025
Q3 2025
-0.28
-0.26
-0.23
-0.21

Details

Expected EPS
-0.22
Actual EPS
-0.28
Surprise EPS
-0.06
Surprise Percent
+27.27%

Description

Rein Therapeutics (RNTX) has reported earnings of -0.28 per share for Q3 2025.

0 Comments

Share your thoughts